## FCX: Freeport-McMoRan Inc. - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 6.3% in lower entry zone (4.0-10.0%), top quartile (88th pct) cross-sectional ranking. Short-term MRS_5 (2.0%) confirms momentum alignment. Strong momentum (+1.5% 5-day acceleration). Outperforming sector by 7.6%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($42.20)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 1, Bearish: 7)

**1. Freeport-McMoRan Inc. Securities Fraud Class Action Lawsuit**
- Source: GlobeNewswire | 20251205T140838 | Bearish | Relevance: 100%
- Levi & Korsinsky, LLP has notified investors of Freeport-McMoRan Inc. (NYSE: FCX) about a class action securities lawsuit. The lawsuit alleges that Freeport-McMoRan made false statements and concealed inadequate safety measures at its Grasberg Block Cave mine, leading to heightened regulatory, litigation, and reputational risks. Investors who suffered losses between February 15, 2022, and September 24, 2025, have until January 12, 2026, to request to be appointed as lead plaintiff.

**2. Freeport-McMoRan Inc. (FCX) Investors are Encouraged to Act**
- Source: GlobeNewswire | 20251205T140838 | Bearish | Relevance: 100%
- Bleichmar Fonti & Auld LLP has filed a class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX) and its executives for securities fraud following significant stock drops. The lawsuit alleges that Freeport overstated its safety commitment, leading to unsafe mining practices at the Grasberg mine and several worker fatalities. Investors who lost money are encouraged to join the class action before the January 12, 2026 deadline.

**3. Contact The Gross Law Firm by January 12, 2026 Deadline to Join Class Action Against Freeport-McMoRan Inc.(FCX)**
- Source: Morningstar | 20251205T110840 | Bearish | Relevance: 100%
- The Gross Law Firm has issued a notice to shareholders of Freeport-McMoRan Inc. (NYSE: FCX) regarding a class action lawsuit. Shareholders who purchased FCX shares between February 15, 2022, and September 24, 2025, are encouraged to contact the firm about potentially becoming lead plaintiff, with a deadline of January 12, 2026. The lawsuit alleges that Freeport-McMoRan issued materially false or misleading statements concerning safety at its Grasberg Block Cave mine in Indonesia and failed to disclose heightened risks.

**4. FCX Stockholders Have Opportunity to Lead Freeport-McMoRan Inc. Class Action Lawsuit â€“ Contact Bronstein, Gewirtz and Grossman, LLC Today!**
- Source: KFOR | 20251204T210758 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX) for alleged violations of federal securities laws. The lawsuit claims that Freeport made false or misleading statements regarding safety at its Grasberg Block Cave mine, leading to undisclosed risks and investor damages. Investors who purchased Freeport securities between February 15, 2022, and September 24, 2025, are encouraged to contact the law firm to learn about their opportunity to participate as lead plaintiff by January 12, 2026.

**5. Copper giant Freeport's CEO won't count on mergers for growth**
- Source: Reuters | 20251204T155014 | Bullish | Relevance: 100%
- Freeport-McMoRan CEO Kathleen Quirk stated that while the company is open to merger and acquisition opportunities, it is not relying on them for growth. Instead, Freeport expects to achieve up to 50% growth in its U.S. business over the next five years through internal organic growth initiatives. Quirk made these remarks at the Reuters NEXT conference in New York.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | JP Morgan | $58 | $50 | +16% |
| 2025-11-19 | Morgan Stanley | $44 | $46 | -4% |
| 2025-11-19 | BMO Capital | $47 | $48 | -2% |
| 2025-11-19 | Scotiabank | $47 | $51 | -8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-11-19 | Morgan Stanley | main | Overweight |
| 2025-11-19 | BMO Capital | main | Outperform |
| 2025-11-19 | Scotiabank | up | Sector Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.05M) |
| Sells | 3 ($1.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.4%)
- Blackrock Inc.: 7.4% (+0.6%)
- Fisher Asset Managem: 4.4% (+1.4%)
- State Street Corpora: 4.3% (+1.1%)
- Capital Research Glo: 2.9% (-31.2%)

### Key Risks

1. Valuation risk: PEG 4.5x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +1.5% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 4.54 signals overvaluation risk, limited margin of safety. Forward P/E 19.7x attractive for 49% earnings growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment negative (3 target cuts vs 1 raises). Insider selling cluster ($1.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $76.2B |
| Beta | 1.48 |
| 52W Range | $27.66 - $53.77 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.54 |
| Forward P/E | 19.7 |
| Current P/E | 29.4 |
| YoY Growth | 49.3% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from 4.8% to 6.3% (+1.5% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 88th percentile. MRS_5 at 2.0% confirms short-term momentum alignment. AM_20 at 8.7% shows strong absolute momentum above own 20MA. Outperforming sector by 7.6pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.53), confirming momentum. OFD pattern: -DUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.30% (CS: 89) | Strong |
| RSI_14 | 66.8 | Neutral |
| MACD Histogram | 0.53 | Bullish |
| vs SMA20 | 1.087x | Above |
| vs SMA50 | 1.101x | Above |
| vs SMA200 | 1.115x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $45.20
- **Stop Loss:** $42.20 (6.6% risk)
- **Target:** $49.70 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 166
- **Position Value:** $7,503.20
- **Portfolio %:** 7.50%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $0.50 | +22.8% |
| 2025Q2 | $0.44 | $0.54 | +21.8% |
| 2025Q1 | $0.23 | $0.24 | +4.6% |
| 2024Q4 | $0.22 | $0.31 | +43.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*